Lv61
2545 积分 2020-12-06 加入
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
7小时前
已完结
Structural biology of the human papillomavirus
1个月前
已完结
Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects: A comprehensive review
3个月前
已完结
Tumour hypoxia in driving genomic instability and tumour evolution
3个月前
已完结
Cellular Senescence in The Cancer Microenvironment
3个月前
已完结
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
3个月前
已完结
Targeting the tumour vasculature: from vessel destruction to promotion
3个月前
已完结
Exploiting temporal aspects of cancer immunotherapy
3个月前
已完结
CAR T therapy from haematological malignancies to aging‐related diseases: An ever‐expanding universe
3个月前
已完结
Recreating metabolic interactions of the tumour microenvironment
3个月前
已完结
皖公网安备34019202002308
